You have no idea how helpful that comment is. S
Post# of 148286
So far we are not better than Remdesivir ( not enough data/patients). NP can tell us how much money he raised in the past another twenty times but his most recent Fife deal sucks. Wouldn't we have been better off doing a raise at $3/share instead of what we have which is a high fee/interest loan that will likely lead to substantial dilution at a far lower than $10/share? Why did he deal with Fife again? To make people think CYDY was going to $10 or $20 or triple digits before the end of the term?
We need management to start thinking in new ways. Better communication (not more). Better governance. Better partnering.